TGFB1 and age-related macular degeneration: The iRPE cells in our study were resistant to TGF-β-induced EMT in vitro and maintained their RPE characteristics in vivo, suggesting that the development of EMT-resistant RPE cells is a novel strategy for the treatment of AMD based on RPE cell transplantation.